Basal Analog denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for basal analog are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Prior Authorization for Basal Analog Insulin

UnitedHealthcare requires prior authorization (PA) for most basal analog insulins. This is a coverage gate — not a coverage denial — meaning the plan will cover the medication only after your prescriber submits clinical documentation demonstrating that the coverage criteria are met. PA is not a judgment that the medication is inappropriate; it is an administrative requirement that your care team must satisfy before coverage is activated. Failure to obtain PA before dispensing results in a claim denial, but the prescription itself has not been rejected on clinical grounds.

## Why a PA Denial Is Appealable

If a PA request was submitted and denied, you have the right to appeal. If the prescription was filled without PA and the claim was denied on that basis, your prescriber can submit a retrospective PA request alongside an appeal. Either way, the appeal should demonstrate that the clinical criteria in UnitedHealthcare's coverage policy are met — point by point — using documentation from your chart.

## Your Federal Appeal Rights

• Internal appeal (Level 1): File within the deadline on your denial letter. A PA denial is a coverage decision subject to the same appeal rights as any other denial.
• External review (ACA §2719 / ERISA §503): If the internal appeal fails, you are entitled to binding independent review. The external-review window is approximately four months from the final internal denial — confirm the exact deadline on your paperwork.
• Expedited appeal: Available when the standard timeline poses a risk to health. Insulin is a life-sustaining medication and commonly qualifies for expedited review.

## Documents to Gather

1. Diagnosis confirmation — office notes or specialist letters confirming the diagnosis and clinical basis for insulin therapy. 2. Prior treatment history — documented history of other diabetes management approaches tried, including dates and outcomes, to satisfy any step-therapy component of the PA criteria. 3. Clinical severity documentation — chart notes reflecting current glycemic status and the clinical rationale for a basal analog. 4. Prescriber medical-necessity letter — a detailed letter from your prescriber addressed to UnitedHealthcare, confirming that all PA criteria are met and citing the specific policy requirements.

## Criteria-Mapping Structure

Request UnitedHealthcare's prior authorization criteria for basal analog insulins. Build a compliance table:

| PA Criterion | Satisfying Documentation | |---|---| | Diagnosis of insulin-requiring diabetes | [chart note + date] | | Prescriber specialty / attestation | [prescriber name, credentials, letter date] | | Prior therapy documented (if step required) | [medication history with dates and outcomes] | | Clinical severity / necessity | [relevant chart findings] |

Submit this table with the PA reconsideration or appeal. Plans are required to evaluate PA appeals against their own published criteria — a structured, criteria-matched submission is the most efficient path to approval.